一项随机试验比较了吸入胰岛素加基础胰岛素与1型糖尿病成年人的常规护理
Irl B Hirsch1, Roy W Beck2, Martin C Marak2
1University of Washington, Seattle, WA.
Diabetes care
|December 6, 2024
概括
吸入的Technosphere胰岛素 (TI) 加上insulin degludec与1型糖尿病管理的通常护理无差. 这种方案为寻求减少食后高血糖症的个人提供了一个选择.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 1型糖尿病的管理通常涉及复杂的胰岛素疗法.
- 自动化胰岛素输送系统 (AID) 和连续血糖监测 (CGM) 的多次每日注射 (MDI) 是常见的治疗方式.
- 优化血糖控制,特别是食后高血糖症,仍然是一个关键的挑战.
研究的目的:
- 评估Technosphere吸入型胰岛素 (TI) 与胰岛素降解剂 (degludec) 结合的疗效和安全性.
- 为了比较这种新的治疗方案与1型糖尿病成年人的常规护理 (UC).
- 评估对血糖控制的影响,特别是HbA1c水平的影响.
主要方法:
- 一项为期17周的随机对照试验,涉及123名1型糖尿病成年人.
- 参与者被分配到TI加上胰岛素降解剂或UC (继续他们的研究前的AID或MDI疗法).
- 在基线和研究结束时测量HbA1c水平.
主要成果:
- 在维持HbA1c水平方面,TI加上胰岛素降解剂疗法与UC无差 (调整后的差异为0.11%,P=0.01无差).
- 与UC组相比,TI组的更大比例的参与者显示HbA1c (>0.5%) 的改善 (21%对5%).
- 最常见的副作用是短暂的咳,导致八名参与者停止治疗.
结论:
- 吸入的Technosphere胰岛素与胰岛素降解糖 (insulin degludec) 结合,是1型糖尿病管理的可行的非劣质选择.
- 这种方案可能对旨在减少食后高血糖症的个人特别有益.
- 对于有动力改善血糖控制的1型糖尿病患者,需要进一步考虑TI.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
145
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
145
Diabetes: Management and Pharmacotherapy
235
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
235
Insulin Formulations: Types and Delivery
167
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
167
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237


